Arvinas competitorsClear all

Arvinas's top competitors include Inhibitor Therapeutics, Dauntless Pharmaceuticals, Actuate Therapeutics and Vor Biopharma.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Inhibitor Therapeutics
Inhibitor Therapeutics
Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biopharmaceutical company focused on the development of specialty drugs.
Actuate Therapeutics
Actuate Therapeutics
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.
Vor Biopharma
Vor Biopharma
Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer.
Founding Date
Founding Date
N/A
Founding Date
1992
Founding Date
2015
Founding Date
2015
Founding Date
2016
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
New Haven, US HQ
Locations
Tampa, US HQ
Locations
San Diego, US HQ
Locations
Fort Worth, US HQ
Dublin, IE
Locations
Cambridge, US HQ
Employees
Employees
13329% increase
Employees
233% decrease
Employees
3
Employees
N/A
Employees
5
Valuation ($)
Valuation ($)
937.4 m
Valuation ($)
21.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
1.5 k
Twitter followers
75
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
332663
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
297747
Alexa Website Rank
384862

Financial

Net income
Net income
($70.3m) (FY, 2019)
Net income
($2.7m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 25m (over 3 years ago)
Latest funding round
$ 6.5m (11 months ago)
Latest funding round
$ 110m (4 months ago)
Total funding raised
Total funding raised
$ 111.6m
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 31.2m
Total funding raised
$ 152m
For sources of this data, please see the company profile

View company profiles

Inhibitor Therapeutics
HQ
Tampa, US
Employees
2↓ 33% decrease

Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.

View company
Dauntless Pharmaceuticals
HQ
San Diego, US
Employees
3

Dauntless Pharmaceuticals is a biopharmaceutical company focused on the development of specialty drugs.

View company
Actuate Therapeutics
HQ
Fort Worth, US

Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.

View company
Vor Biopharma
HQ
Cambridge, US
Employees
5

Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer.

View company